MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 103 filers reported holding MAXCYTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,516,199 | -36.4% | 2,409,038 | -6.5% | 0.09% | -30.0% |
| Q2 2023 | $11,825,033 | +3.9% | 2,576,260 | +12.1% | 0.13% | +0.8% |
| Q1 2023 | $11,380,416 | -7.7% | 2,299,074 | +1.8% | 0.13% | -12.2% |
| Q4 2022 | $12,329,947 | -14.9% | 2,258,232 | +1.4% | 0.15% | -17.4% |
| Q3 2022 | $14,483,000 | +42.1% | 2,228,099 | +3.4% | 0.18% | +52.1% |
| Q2 2022 | $10,190,000 | +12.8% | 2,154,237 | +66.6% | 0.12% | +48.1% |
| Q1 2022 | $9,036,000 | -27.4% | 1,292,713 | +5.8% | 0.08% | -21.0% |
| Q4 2021 | $12,450,000 | -13.4% | 1,221,750 | +3.7% | 0.10% | -11.5% |
| Q3 2021 | $14,382,000 | – | 1,177,924 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
| Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
| Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
| Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
| RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
| Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
| Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
| Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
| First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
| Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |